Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
about
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.
P2860
Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
description
1984 nî lūn-bûn
@nan
1984 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մարտին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Addition of cisplatin and bleo ...... outhwest Oncology Group study.
@ast
Addition of cisplatin and bleo ...... outhwest Oncology Group study.
@en
type
label
Addition of cisplatin and bleo ...... outhwest Oncology Group study.
@ast
Addition of cisplatin and bleo ...... outhwest Oncology Group study.
@en
prefLabel
Addition of cisplatin and bleo ...... outhwest Oncology Group study.
@ast
Addition of cisplatin and bleo ...... outhwest Oncology Group study.
@en
P2093
P1476
Addition of cisplatin and bleo ...... outhwest Oncology Group study.
@en
P2093
P304
P577
1984-03-01T00:00:00Z